7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection
| dc.contributor.author | Vecchione, María Belén | |
| dc.contributor.author | Laufer, Natalia | |
| dc.contributor.author | Omar, Sued | |
| dc.contributor.author | Corti, Marcelo | |
| dc.contributor.author | Salomon, Horacio | |
| dc.contributor.author | Quiroga, Maria Florencia | |
| dc.date.accessioned | 2024-05-23T23:49:38Z | |
| dc.date.available | 2024-05-23T23:49:38Z | |
| dc.date.issued | 2020-01-06 | |
| dc.description | Fil: Sued O. Fundación Huésped, Buenos Aires; Argentina | es_ES |
| dc.description.abstract | Background Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), affecting approximately one third of the world’s population. Development of an adequate immune response will determine disease progression or progress to chronic infection. Risk of developing TB among human immunodeficiency virus (HIV)-coinfected patients (HIV-TB) is 20–30 times higher than those without HIV infection, and a synergistic interplay between these two pathogens accelerates the decline in immunological functions. TB treatment in HIV-TB coinfected persons is challenging and it has a prolonged duration, mainly due to the immune system failure to provide an adequate support for the therapy. Therefore, we aimed to study the role of the hormone 7-oxo-dehydroepiandrosterone (7-OD) as a modulator of anti-tuberculosis immune responses in the context of HIV-TB coinfection. Methods A cross-sectional study was conducted among HIV-TB patients and healthy donors (HD). We characterized the ex vivo phenotype of CD4 + T cells and also evaluated in vitro antigen-specific responses by Mtb stimulation of peripheral blood mononuclear cells (PBMCs) in the presence or absence of 7-OD. We assessed lymphoproliferative activity, cytokine production and master transcription factor profiles. Results Our results show that HIV-TB patients were not able to generate successful anti-tubercular responses in vitro compared to HD, as reduced IFN-γ/IL-10 and IFN-γ/IL-17A ratios were observed. Interestingly, treatment with 7-OD enhanced Th1 responses by increasing Mtb-induced proliferation and the production of IFN-γ and TNF-α over IL-10 levels. Additionally, in vitro Mtb stimulation augmented the frequency of cells with a regulatory phenotype, while 7-OD reduced the proportion of these subsets and induced an increase in CD4 + T-bet+ (Th1) subpopulation, which is associated with clinical data linked to an improved disease outcome. Conclusions We conclude that 7-OD modifies the cytokine balance and the phenotype of CD4 + T cells towards a more favorable profile for mycobacteria control. These results provide new data to delineate novel treatment approaches as co-adjuvant for the treatment of TB. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.identifier.doi | https://doi.org/10.1186/s12929-019-0604-z | |
| dc.identifier.uri | https://repositorio.huesped.org.ar/handle/123456789/1383 | |
| dc.language | ENG | es_ES |
| dc.provenance | Published | es_ES |
| dc.relation.ispartofseries | Journal of Biomedical Science;2020 Jan 6;27(1):20 | |
| dc.rights | openAccess | es_ES |
| dc.subject | Mycobacterium tuberculosis | es_ES |
| dc.subject | HIV | es_ES |
| dc.title | 7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection | es_ES |
| dc.type | Articulo | es_ES |